Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Tenon Medical (TNON) Change in Acquisitions & Divestments (2022 - 2023)

Tenon Medical has reported Change in Acquisitions & Divestments over the past 2 years, most recently at $493000.0 for Q3 2023.

For Q3 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $493000.0; the TTM value through Dec 2023 reached $7.0 million, down 13.41%, while the annual FY2023 figure was $7.0 million, 13.41% down from the prior year.
Change in Acquisitions & Divestments for Q3 2023 was $493000.0 at Tenon Medical, down from $1.8 million in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $4.8 million in Q1 2023 and troughed at $493000.0 in Q3 2023.